Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Neuropsychiatric Disease and Treatment|June 10, 2011
Once-daily pramipexole for the treatment of early and advanced idiopathic Parkinson's disease: implications for patientsAngelo Antonini, Daniela CalandrellaParkinsonism & Related Disorders|December 15, 2011
Pulsatile or continuous dopaminomimetic strategies in Parkinson's diseaseDaniela Calandrella, Angelo AntoniniExpert Review of Neurotherapeutics|June 10, 2011
Pathological gambling in Parkinson's disease: disease related or drug related?Daniela Calandrella, Angelo AntoniniExpert Opinion on Drug Metabolism & Toxicology|September 7, 2011
Pharmacokinetic evaluation of pramipexoleAngelo Antonini, Daniela CalandrellaParkinsonism & Related Disorders|April 28, 2004
Caribbean parkinsonism and other atypical parkinsonian disordersEduardo Tolosa, Daniela Calandrella, Marisol GallardoMovement Disorders : Official Journal of the Movement Disorder Society|August 25, 2015
Therapeutic advances in dystoniaAlberto Albanese, Luigi M Romito, Daniela CalandrellaMovement Disorders : Official Journal of the Movement Disorder Society|February 19, 2009
Botulinum neurotoxins for post-stroke spasticity in adults: a systematic reviewAntonio Emanuele Elia, Graziella Filippini, Daniela Calandrella, et al.Functional Neurology|July 15, 2010
Rotigotine transdermal patch in the management of Parkinson's disease (PD) and its night-time use for PD-related sleep disordersAngelo Antonini, Laura Bernardi, Daniela Calandrella, et al.Expert Opinion on Pharmacotherapy|October 22, 2013
Effects of rotigotine on Parkinson's disease-related sleep disturbancesAngelo Antonini, Daniela Calandrella, Marcelo Merello, et al.Journal of Neurology|November 17, 2010
Continuous dopaminergic delivery in Parkinson's diseaseAngelo Antonini, Giulia Ursino, Daniela Calandrella, et al.Pageof 4